Testing a computer tool for colorectal liver metastasis prognosis
Part of Cancer clinical trials.
This trial is testing a computer program that helps doctors predict outcomes for people with colorectal cancer that has spread to the liver. It is for patients who have had surgery to remove both the colon and liver tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with colorectal cancer that spread to your liver and confirmed by biopsy
- You had surgery to remove both the colon tumor and liver tumors at the same time
- You do not have any other types of cancer
- You have follow-up data available (medical records after surgery)
- If you were followed for less than 5 years after surgery and are still alive, you may not qualify
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of drugs for people with colorectal cancer that has spread to the liver and cannot be removed by surgery. It aims to shrink or control these liver tumors.
This study uses your liver MRI scans and medical information to build a tool that predicts survival after surgery for colorectal cancer that has spread to the liver. It may help doctors better understand your outlook and plan care.
This study looks at whether an AI tool can predict if colorectal cancer will spread to the liver. The researchers will review past medical records of patients who had surgery to remove their cancer and had no signs of spread at that time.
This study looks at your tumor's genetic makeup and a blood test after surgery to better predict if colorectal cancer that spread to the liver might come back early. The goal is to personalize follow-up care and potentially guide additional treatments.
This trial studies a “liver-first” approach for colorectal cancer that has spread mainly to the liver, to see if it can help more people have the tumor(s) removed or treated. You may be eligible if your liver involvement is too extensive for immediate surgery but could become treatable after a specific plan.
This study looks at tissue from colorectal cancer surgery to understand how cancer cells use energy, which may help find better treatments. It is open to adults having surgery for colorectal cancer or liver metastases from colorectal cancer.
Hear when a new Colorectal Liver Metastasis (CRLM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.